2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow vactosertib: new trials by email Literature Review of vactosertib trials Research Report on vactosertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers Vactosertib - Gastric Cancer | Phase 2 | Unknown | Samsung Medical Center | 43 | 2022-10-01 | 2022-06-15 |
| Vactosertib and Durvalumab in Gastric Cancer durvalumab and vactosertib - Stomach Neoplasm | Phase 2 | Unknown | Hark Kyun Kim | 55 | 2021-06-01 | 2022-11-30 |
Hark Kyun Kim (1) · Samsung Medical Center (1)
South Korea (1)